Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis-Reference-Cited by-同舟云学术

Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis

Published:2019-10 Issue:4 Volume:144 Page:1011-1024
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Pavel Ana B.,Song Teresa,Kim Hyun-Je,Del Duca Ester,Krueger James G.,Dubin Celina,Peng Xiangyu,Xu Hui,Zhang Ning,Estrada Yeriel D.,Denis Louis,Rao Niranjan,Gupta Sandeep,Zammit David J.,Bissonnette Robert,Guttman-Yassky Emma^ORCID

Funder

Asana BioSciences

Abbvie

Celgene

Eli Lilly

Janssen

MedImmune

AstraZeneca

Novartis

Pfizer

Regeneron

Vitae

Glenmark

Galderma

Asana

Innovaderm

Dermira

UCB

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference104 articles.

1. Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities;Mortz;Allergy,2015

2. A multinational study to compare prevalence of atopic dermatitis in the first year of life;Draaisma;Pediatr Allergy Immunol,2015

3. Epidemiology of atopic dermatitis in adults: results from an international survey;Barbarot;Allergy,2018

4. New pathogenic and therapeutic paradigms in atopic dermatitis;Malajian;Cytokine,2015

5. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis;Beck;N Engl J Med,2014

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restoration of Skin Barrier Abnormalities with IL4/13 Inhibitors and Jak Inhibitors in Atopic Dermatitis: A Systematic Review;Medicina;2024-08-22

2. Recent progress in tyrosine kinase 2 inhibitors for atopic dermatitis;Expert Opinion on Investigational Drugs;2024-08-21

3. Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations;Journal of Allergy and Clinical Immunology;2024-07

4. Integrating multi‐omics approaches in deciphering atopic dermatitis pathogenesis and future therapeutic directions;Allergy;2024-06-04

5. Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis;Critical Reviews in Oncology/Hematology;2024-05